Skip to main content

I Felt Like Rip Van Winkle’: One Of First U.S. Doctors With COVID-19 Is Back Home

Photo caption:

Photo by Martin Kaste NPR

Dr. Ryan Padgett is back home in Seattle after a 24-day hospitalization for COVID-19. He was one of the first American health care workers to develop a life-threatening case of the disease.

In mid-March, he was a cautionary tale for medical workers: an unnamed doctor "in his 40s" with a case of COVID-19 so bad, he was near death.

Almost a month later, 45-year-old emergency physician Ryan Padgett is back in his home in Seattle, rebuilding his strength and marveling at how quickly the novel virus laid him low.

"This is very scary," he says. "That it's not only medically fragile patients, but young people can be cut at the knees and taken down by this."

Padgett works at EvergreenHealth, the hospital in suburban Seattle that saw the country's first known COVID-19 deaths at the end of February, primarily patients from the Life Care nursing home.

At first, he says he just had a headache and some muscle soreness, but within just a few days his health took a sharp downturn.

"It becomes a big deal when you realize you can't breathe," he says.

It took the urging of his fiancee, Connie Kinsley, to get him back to hospital. "He didn't want to," she says, "because doctors are the worst patients."

Within hours of getting to EvergreenHealth, they were putting him on a ventilator.

"I have no personal recollection, but evidently I told [Kinsley] where some important documents were, just in case," he says. "And the next memory I had was about 16 days later, waking up at Swedish Hospital."

While he was unconscious, he'd been transferred to a different hospital — Swedish Medical Center near downtown Seattle, because it's one of only two hospitals in the state with an extreme form of life support called extracorporeal membrane oxygenation, or ECMO. It bypasses the lungs to oxygenate a patient's blood.

"It saved my life," Padgett says of ECMO. "I'd dwindled to the point of my lungs, liver, kidneys and heart, all going into organ failure, multi-system organ failure."

"ECMO allowed us to sustain his life while we tried other therapies," says Dr. Krish Patel, an oncologist at Swedish who helped treat Padgett.

Patel thinks the drug that may have made the difference was something called "tocilizumab," an immunosuppressive therapy for conditions such as rheumotoid arthritis. The hope is that it can also tame the immune system overreactions known as "cytokine storms" which can ravage a COVID-19 patient's organs.

The same drug has been tried on other patients, and Swedish is now taking part in a broader trial of its effectiveness.

Padgett is impressed by how quickly medicine's understanding of COVID-19 has changed, just during the weeks he was sedated and on a ventilator.

"Not only has the understanding of the illness changed, but the world changed," he says. "I felt like Rip Van Winkle, waking up ... and realizing that the world had shut down."

He also found out his May 16 wedding had been postponed. He and his fiancee don't seem too concerned about it.

"Perspective changes, I tell you," Padgett says. "When you survive something like I survived, you realize that's all window dressing. It doesn't matter."

Copyright 2020 NPR. To see more, visit https://www.npr.org.

FEATURED PODCAST

San Diego News Now podcast branding

San Diego news; when you want it, where you want it. Get local stories on politics, education, health, environment, the border and more. New episodes are ready weekday mornings. Hosted by Anica Colbert and produced by KPBS, San Diego and the Imperial County's NPR and PBS station.

  • Need help keeping up with the news that matters most? Get the day's top news — ranging from local to international — straight to your inbox each weekday morning.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Curious San Diego banner

Want more KPBS news?
Find us on Twitter and Facebook, or sign up for our newsletters.

To view PDF documents, Download Acrobat Reader.